Related Experiment Video
Updated: Jan 7, 2026

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
Published on: April 25, 2025
Comparing discriminatory behavior against AI and humans
Mike Zhuang1, Eliane Deschrijver2, Richard Ramsey3,4
1School of Computing and Information Systems, The University of Melbourne, Parkville, VIC, 3052, Australia. mikez@unimelb.edu.au.
Abstract:
Although discrimination is typically believed to occur from well-defined categories like ethnicity, disability, and sex, studies have found that discrimination persists in minimal conditions lacking such categories. Participants have been found to preferentially allocate resources based on seemingly arbitrary shared characteristics such as dot estimation choices. Here, we use a preregistered experiment (n = 500) to investigate whether humans discriminate in a similar manner when interacting with artificial intelligence (AI) agents that ostensibly made dot estimations. We hypothesized that because humans harbor prejudice against algorithms relative to other humans (otherwise known as algorithm aversion), the strength of discriminatory behavior may be greater against AI than humans. Surprisingly, we found that participants distributed resources in a similar manner, albeit unequally, to both human and AI agents. Specifically, participants favored the other agent when decisions were aligned. Our findings suggest that discriminatory behavior is less influenced by the recipient's identity and more shaped by choice congruency.
Related Concept Videos
05:12Murine Nasal Lavage Fluid Collection without Blood Contamination
03:40Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
04:35Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
08:47Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
07:15Intranasal Administration of CNS Therapeutics to Awake Mice

